Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus
- PMID: 2843776
- DOI: 10.1038/335452a0
Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus
Abstract
A virion protein of herpes simplex virus type 1 (HSV-1) specifically and potently activates transcription of the viral immediate early genes. Appropriate function of this protein, termed VP16, depends on an acidic transcriptional activation domain located within the 78 carboxyl-terminal amino acids of the protein. Mutated forms of the protein lacking this acidic domain lose the ability to activate transcription, and can dominantly interfere with the trans-activation function of native VP16 (ref. 1). We have prepared stably transformed mouse L cells that constitutively express a form of VP16 lacking its acidic activating domain. In this report we show that these cells are selectively impaired in their capacity to support the lytic infectious cycle of HSV-1, and that this impairment results from their inability to support immediate early transcription.
Similar articles
-
Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function.EMBO J. 1996 May 15;15(10):2575-81. EMBO J. 1996. PMID: 8665865 Free PMC article.
-
Function of Rta is essential for lytic replication of murine gammaherpesvirus 68.J Virol. 2001 Oct;75(19):9262-73. doi: 10.1128/JVI.75.19.9262-9273.2001. J Virol. 2001. PMID: 11533188 Free PMC article.
-
The equine herpesvirus type 1 immediate-early gene product contains an acidic transcriptional activation domain.Virology. 1994 Aug 1;202(2):760-70. doi: 10.1006/viro.1994.1398. Virology. 1994. PMID: 8030239
-
Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.Virology. 1995 May 10;209(1):19-28. doi: 10.1006/viro.1995.1227. Virology. 1995. PMID: 7747469
-
The octamer binding protein Oct-2 inhibits transactivation of the herpes simplex virus immediate-early genes by the virion protein Vmw65.Virology. 1993 Oct;196(2):888-91. doi: 10.1006/viro.1993.1552. Virology. 1993. PMID: 8396817
Cited by
-
A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.Proc Natl Acad Sci U S A. 1990 Jul;87(13):5079-83. doi: 10.1073/pnas.87.13.5079. Proc Natl Acad Sci U S A. 1990. PMID: 2195547 Free PMC article.
-
Transgenic regulation in laboratory animals.Experientia. 1991 Sep 15;47(9):866-77. doi: 10.1007/BF01929876. Experientia. 1991. PMID: 1915769 Review.
-
Disease resistance in farm animals.Experientia. 1991 Sep 15;47(9):923-34. doi: 10.1007/BF01929883. Experientia. 1991. PMID: 1915776 Review.
-
Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon.Proc Natl Acad Sci U S A. 1989 Jul;86(13):4958-62. doi: 10.1073/pnas.86.13.4958. Proc Natl Acad Sci U S A. 1989. PMID: 2472636 Free PMC article.
-
Viral complementation allows HIV-1 replication without integration.Retrovirology. 2008 Jul 9;5:60. doi: 10.1186/1742-4690-5-60. Retrovirology. 2008. PMID: 18613957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources